These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 200493)

  • 41. [The insulin-secreting and proliferative activity of established islet cells in the presence of sulfonylurea].
    Balabolkin MI; Timofeev AV; Danilova TI; Zhuleva LIu; Ol'shanskaia AA
    Biull Eksp Biol Med; 1992 Oct; 114(10):406-8. PubMed ID: 1288706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drugs and the mechanism of insulin secretion.
    Kizer JS; Bressler R
    Adv Pharmacol (1962); 1969; 7():91-115. PubMed ID: 4313761
    [No Abstract]   [Full Text] [Related]  

  • 43. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets.
    Lambillotte C; Gilon P; Henquin JC
    J Clin Invest; 1997 Feb; 99(3):414-23. PubMed ID: 9022074
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exchange protein directly activated by cyclic AMP isoform 2 is not a direct target of sulfonylurea drugs.
    Tsalkova T; Gribenko AV; Cheng X
    Assay Drug Dev Technol; 2011 Feb; 9(1):88-91. PubMed ID: 21133673
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppressive effect of long term sulfonylurea treatment on A, B, and D cells of normal rat pancreas.
    Filipponi P; Marcelli M; Nicoletti I; Pacifici R; Santeusanio F; Brunetti P
    Endocrinology; 1983 Dec; 113(6):1972-9. PubMed ID: 6139273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
    Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
    [No Abstract]   [Full Text] [Related]  

  • 47. Long-term actions of sulfonylureas on (pro-) insulin biosynthesis and secretion: I. Lack of evidence for a compensatory increase in (pro-) insulin biosynthesis after exposure of isolated pancreatic rat islets to tolbutamide and glibenclamide in vitro.
    Schatz H; Steinle D; Pfeiffer EF
    Horm Metab Res; 1977 Nov; 9(6):457-65. PubMed ID: 412764
    [No Abstract]   [Full Text] [Related]  

  • 48. [Studies on kinetics of insulin secretion in perifused pancreatic islets of hamster. I. Characteristics of insulin secretory response to various secretagogues].
    Kikuchi M
    Fukuoka Igaku Zasshi; 1987 Feb; 78(2):39-45. PubMed ID: 3556362
    [No Abstract]   [Full Text] [Related]  

  • 49. [Physiologic and pharmacologic influence on insulin secretion].
    Frerichs H; Creutzfeldt W
    Med Klin; 1971 Jun; 66(30):1039-44. PubMed ID: 4328077
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
    Kadowaki S; Taminato T; Chiba T; Nozawa M; Fujita T; Norman AW
    Endocrinology; 1983 Jun; 112(6):2187-92. PubMed ID: 6133743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of hydrocortisone treatment and adrenalectomy on insulin and glucagon secretion from the perfused rat pancreas.
    Lenzen S
    Endokrinologie; 1976; 68(2):189-97. PubMed ID: 795635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blockade of insulin secretion by mannoheptulose.
    Simon E; Frenkel G; Kraicer PF
    Isr J Med Sci; 1972 Jun; 8(6):743-52. PubMed ID: 4626312
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of the daily injection of tolbutamide into pregnant rats on the pancreatic insulin content of their offspring.
    Sodoyez JC; Sodoyez-Goffaux FR
    Metabolism; 1973 Nov; 23(2):1389-93. PubMed ID: 4584187
    [No Abstract]   [Full Text] [Related]  

  • 54. Glucagon-releasing activity of guanidine compounds in mouse pancreatic islets.
    Marco J; Calle C; Hedo JA; Villanueva ML
    FEBS Lett; 1976 Apr; 64(1):52-4. PubMed ID: 773702
    [No Abstract]   [Full Text] [Related]  

  • 55. Glucagon secretion inhibited by nickel in mouse pancreatic islets.
    Calle C; Tamarit J
    Horm Metab Res; 1980 Mar; 12(3):127-8. PubMed ID: 6989736
    [No Abstract]   [Full Text] [Related]  

  • 56. Regulation by glucose and cyclic nucleotides of the glucagon and insulin release induced by amino acids.
    Jarrousse C; Rosselin G
    Diabete Metab; 1975 Sep; 1(3):135-42. PubMed ID: 186341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulfonylurea compounds uncouple the glucose dependence of the insulinotropic effect of glucagon-like peptide 1.
    de Heer J; Holst JJ
    Diabetes; 2007 Feb; 56(2):438-43. PubMed ID: 17259389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of insulin secretion by cyclic AMP and prostaglandin E: the effects of theophylline, sodium salicylate and tolbutamide.
    Metz S; Fujimoto W; Robertson RP
    Metabolism; 1982 Oct; 31(10):1014-22. PubMed ID: 6290835
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of a 5'-substituted adenosine analogue (744c96) on insulin and glucagon release in isolated rat islets of Langerhans.
    Schütz W; Raberger G; Brugger G; Kraupp O
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):88-97. PubMed ID: 384948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Tolbutamide, glucagon, leucine and arginine tolerance test].
    Hosaka T; Oka Y
    Nihon Rinsho; 1997 Apr; 55 Suppl 2():423-7. PubMed ID: 9172561
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.